The use of apatinib in treating primary pleural synovial sarcoma: A case report

RATIONALE: Apatinib is an oral tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2. It has been shown that apatinib is effective and safe for treatment of multiple solid tumors, including gastric cancer, liver cancer, non-small-cell lung cancer, and breast cancer. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Sumei, Zhang, Ke, Wan, Xianqin, Chen, Yuanyuan, Ma, Shenglin, Deng, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940042/
https://www.ncbi.nlm.nih.gov/pubmed/31861000
http://dx.doi.org/10.1097/MD.0000000000018382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6940042/
https://www.ncbi.nlm.nih.gov/pubmed/31861000
http://dx.doi.org/10.1097/MD.0000000000018382

Ejemplares similares